Objectives: To report insidious development of autonomic dysreflexia and hydronephrosis due to dyssynergic voiding following discontinuation of intrathecal baclofen therapy. Setting: Regional Spinal ...
Practitioners from around the country who have extensive experience in intrathecal baclofen (ITB) therapy gathered in early 2004 to develop best-practice guidelines for ITB therapy. Discussion focused ...
September 14, 2012 — The US Food and Drug Administration (FDA) has approved a new catheter (Ascenda, Medtronic Inc) for use in the delivery of intrathecal baclofen (ITB) therapy. According to the ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...
Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) ...
Two traumatic brain-injury patients steadily emerged from minimally conscious state after receiving intrathecal baclofen therapy. At the International Neuromodulation Society's 11th World Congress, Dr ...
Mount Olive, New Jersey-based Flowonix Medical Inc. said Wednesday that the United States Food and Drug Administration granted approval to market the Prometra II Programmable Pump System for use with ...
A 63-year-old patient bed ridden for nearly a year because of paralysis could finally feel the feet under his feet after undergoing intrathecal baclofen (ITB) therapy recently. KOLKATA: A 63-year-old ...
Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The global market for Intrathecal Baclofen (ITB) therapy systems reached a value of USD 1.11 Billion in the year 2022. According to the most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback